HP and chronic atrophic gastritis: A Colombian chemoprevention trial showed that reversal of atrophic gastritis was common in trial participants who remained free of Hp for 6 or more years following baseline therapy; reversal of intestinal metaplasia occurred to a much more limited extent, but Hp-negativity was associated with reduced progression of intestinal metaplasia to more advanced disease [50].